Skip to search formSkip to main contentSkip to account menu

Marcoumar

Known as: Marcumar, Roche Brand of Phenprocoumon 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Phenprocoumon

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Mechanical Valve Replacement in Congenital Heart Defects in the Era of International Normalized Ratio Self-Management
As the number of patients with congenital heart defects requiring heart valve replacement increases, the need for durable valve… 
2001
2001
Thromboseprophylaxe in der Hüftendoprothetik
ZusammenfassungDie tiefe Venenthrombose ist eine der schwerwiegendsten perioperativen Komplikationen nach H… 
1999
1999
[Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
In numerous clinical trials low molecular weight heparins (LMWHs) have proven to be highly efficacious and safe in preventing… 
1998
1998
Behandlung des fortgeschrittenen Budd-Chiari-Syndroms durch Lebertransplantation
Summary. Budd-Chiari syndrome (BCS) with hepatic vein occlusion is a rare disorder that can effectively be treated in advanced… 
1996
1996
25 Years Follow-Up of Patients after Replacement of the Aortic Valve with a Smeloff-Cutter Prosthesis
Thirty years ago the Smeloff-Cutter double-caged ball prosthesis was developed for aortic valve replacement. Between 1967 and… 
1993
1993
Concentrations of phenprocoumon in serum and serum water determined by high-performance liquid chromatography in patients on oral anticoagulant therapy.
Two convenient high-performance liquid chromatography procedures are proposed for the determination of phenprocoumon (Marcumar… 
1976
1976
Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis
SummaryA gas chromatographic method for the determination of phenprocoumon (Marcumar®) in serum and urine is described, which… 
1972
1972
Inhibition of microsomal drug-metabolizing enzymes from rat liver by various 4-hydroxycoumarin derivatives.
1968
1968
Properties of 3-(1-Phenyl-Propyl)-4-Oxycoumarin (Marcoumar®) in the Plasma when Tested in Normal Cases and under the Influence of Drugs
Summary A fluorimetric method served to determine Marcoumar in blood plasma. The biological half-time of Marcoumar after an… 
1957
1957
Effect of Oral Anticoagulant (Marcumar) on Prothrombin and Related Components in Blood Coagulation
Marcumar has been considered as an excellent anticoagulant for long term management. It was found that the effect of the drug on… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)